Show simple item record

dc.contributor.authorBriggs, Andrew
dc.contributor.authorMarch, L.
dc.contributor.authorLassere, M.
dc.contributor.authorReid, C.
dc.contributor.authorHenderson, L.
dc.contributor.authorMurphy, B.
dc.contributor.authorvan den Haak, R.
dc.contributor.authorRischin, A.
dc.contributor.authorStaples, M.
dc.contributor.authorBuchbinder, R.
dc.date.accessioned2017-01-30T14:37:56Z
dc.date.available2017-01-30T14:37:56Z
dc.date.created2015-03-03T20:14:29Z
dc.date.issued2009
dc.identifier.citationBriggs, A. and March, L. and Lassere, M. and Reid, C. and Henderson, L. and Murphy, B. and van den Haak, R. et al. 2009. Baseline comorbidities in a population-based cohort of rheumatoid arthritis receiving biological therapy: Data from the Australian Rheumatology Association database. International Journal of Rheumatology. 2009: Article ID 861481.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/39887
dc.identifier.doi10.1155/2009/861481
dc.description.abstract

Aims. To describe the baseline characteristics of an Australian population-based cohort of rheumatoid arthritis (RA) patients commencing biological therapy. Methods. Descriptive analysis from the Australian Rheumatology Association Database (ARAD). Results. Up to October 2006, there were 681 RA patients taking biologics enrolled in ARAD. Baseline data were available for 624 (72% female, mean (SD) age 57.0 (12.5) years). Of these, 59.5% reported at least one comorbid condition, most commonly hypertension (35.7%) and osteoporosis (30.4%); 61 (9.8%) had a history of malignancy (35 nonmelanoma skin, 5 breast, 4 bowel, 5 cervix, 3 melanoma, 3 prostate and 1 each of lip, lung, myeloma, testis, uterus, vagina). Self-reported infections within the previous 6 months were common (71.5%). Conclusions. History of comorbidities, including recent infections, is common among Australian RA patients commencing biologics, and 10% have a history of malignancy. This may impact future evaluations of health outcomes among this population, including attribution of adverse events of biologic therapy.

dc.publisherHindawi Publishing Company
dc.titleBaseline comorbidities in a population-based cohort of rheumatoid arthritis receiving biological therapy: Data from the Australian Rheumatology Association database
dc.typeJournal Article
dcterms.source.volume2009
dcterms.source.startPage1
dcterms.source.endPage8
dcterms.source.issn1687-9260
dcterms.source.titleInternational Journal of Rheumatology
curtin.note

This article is published under the Open Access publishing model and distributed under the terms of the Creative Commons License http://creativecommons.org/licenses/by/3.0/ Please refer to the licence to obtain terms for any further reuse or distribution of this work

curtin.departmentSchool of Physiotherapy and Exercise Science
curtin.accessStatusOpen access


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record